Patients The state of women’s health in the UK: A parliamentary round... The UK faces one of the largest gender health gaps among G20 nations and women’s health challenges remain significantly, unacceptably underserved.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.